Literature DB >> 2844952

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

L K Borysiewicz1, J K Hickling, S Graham, J Sinclair, M P Cranage, G L Smith, J G Sissons.   

Abstract

CTL are held to be an important host defense mechanism in persistent herpes-virus infections. We have therefore studied the nature and specificity of human cytomegalovirus (HCMV)-specific CTL in normal persistently infected individuals. This was achieved by using vaccinia recombinants encoding viral genes expressed at different stages of the virus replicative cycle, a structural glycoprotein gB (vac.gB) and the major 72-kD immediate early nonstructural protein (vac.IE) of HCMV, combined with limiting dilution analysis of the CTL response. In two subjects, 43 and 58% of HCMV CTL precursors (CTLp) lysed vac.IE-infected cells, in contrast to less than 6% lysing gB-infected cells. HCMV-specific CTL could also be generated by secondary in vitro stimulation with vac.gB- but not vac.IE-infected autologous fibroblasts. The high frequency of 72-kD IE protein-specific CTL suggests that this is at least a major recognition element for the HCMV-specific CTL response in asymptomatic persistently infected individuals, and CTL with this specificity may be important in maintaining the normal virus/host equilibrium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844952      PMCID: PMC2189029          DOI: 10.1084/jem.168.3.919

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.

Authors:  M D Lindsley; D J Torpey; C R Rinaldo
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  The structure of the major immediate early gene of human cytomegalovirus strain AD169.

Authors:  A Akrigg; G W Wilkinson; J D Oram
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

4.  Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

5.  Autoregulation of the human cytomegalovirus major immediate-early gene.

Authors:  R M Stenberg; M F Stinski
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

Review 7.  Viral immunopathology.

Authors:  J G Sissons; L K Borysiewicz
Journal:  Br Med Bull       Date:  1985-01       Impact factor: 4.291

8.  Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection.

Authors:  M J Reddehase; U H Koszinowski
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

9.  Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

10.  Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.

Authors:  R D Schrier; J A Nelson; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

View more
  64 in total

1.  Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Authors:  R Holtappels; J Podlech; N K Grzimek; D Thomas; M F Pahl-Seibert; M J Reddehase
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Cross-reactivity of HLA-B*1801-restricted T-lymphocyte clones with target cells expressing variants of the human cytomegalovirus 72kDa-IE1 protein.

Authors:  Virginie Prod'homme; Christelle Retière; Ralitza Valtcheva; Marc Bonneville; Marie-Martine Hallet
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old.

Authors:  Qin Ouyang; Wolfgang M Wagner; Anders Wikby; Steffen Walter; Geraldine Aubert; Anthony I Dodi; Paul Travers; Graham Pawelec
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

4.  Mechanism of escape of endogenous murine leukemia virus emv-14 from recognition by anti-AKR/Gross virus cytolytic T lymphocytes.

Authors:  H D White; M D Robbins; W R Green
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 5.  Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.

Authors:  D J Moss; I S Misko; T B Sculley; A Apolloni; R Khanna; S R Burrows
Journal:  Springer Semin Immunopathol       Date:  1991

Review 6.  CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.

Authors:  Rafaela Holtappels; Verena Böhm; Jürgen Podlech; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2008-03-15       Impact factor: 3.402

7.  Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.

Authors:  K Furukawa; M Mori; N Ohta; H Ikeda; H Shida; K Furukawa; H Shiku
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.

Authors:  A Maeda; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans.

Authors:  Y N Liu; A Klaus; B Kari; M F Stinski; J Eckhardt; R C Gehrz
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.

Authors:  S M Morgan; G W Wilkinson; E Floettmann; N Blake; A B Rickinson
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.